Junshi Biotech announced that Shanghai Tanying Investment Partnership, the shareholder holding more than 5% of the company's shares, has expired. It reduced its holdings of the company's A shares by a total of 205.337 million shares through bulk transactions, accounting for 2% of the company's total share capital. The reduced price range was 28.73 yuan/share - 39.87 yuan/share, with a total reduction of 707 million yuan. After this reduction in holdings, Shanghai Tanying held 389.256 million shares of the company, with a shareholding ratio of 3.7914%. This holdings reduction complies with relevant laws and regulations and the previously disclosed holdings reduction plan requirements.

Junshi Biotech announced that Shanghai Tanying Investment Partnership, the shareholder holding more than 5% of the company's shares, has expired. It reduced its holdings of the company's A shares by a total of 205.337 million shares through bulk transactions, accounting for 2% of the company's total share capital. The reduced price range was 28.73 yuan/share - 39.87 yuan/share, with a total reduction of 707 million yuan. After this reduction in holdings, Shanghai Tanying held 389.256 million shares of the company, with a shareholding ratio of 3.7914%. This holdings reduction complies with relevant laws and regulations and the previously disclosed holdings reduction plan requirements.